UBASE LIFE BIO HEALTH is our solution that provides physicians the testing capabilities to address early detection in their practice. Supported by a team of world leading scientists and researchers who provide education, interpretation and consultation, our lab partners across the country continue to create unique tests to help us better understand the over 3 billion letters of our genetic code. Allow us to share with you how our Genomics platform can enhance the performance of your practice and improve your patient outcomes.
Cancer screenings are the beginning of prevention, diagnosis and treatment of diseases. As a medical provider, you want to improve the lives of your patients while maintaining their quality of life. Our laboratory partner’s hereditary cancer test panels analyze the most frequent syndromes that present predisposition to cancer. These panels cover an analysis of 31 genes associated with the diseases, increasing the accuracy of diagnosis and treatment. Early diagnosis based on preventive tests is highly important and can save a patient’s life.
Hereditary Cancer Test Panels
A non-invasive genetic screen that provides data to aid providers in determining the patient’s risk profile for developing eight genetically linked cancers.
THE GENETICS OF INHERITED CONDITIONS TESTR
The Inherited Conditions Test detects variations in 157 significant genes contributing to 123 inherited conditions. .The Carrier Screening laboratory-developed test offers you and your partner the information needed to identify if you are carriers of genetic disorders that can be passed down in families and provide vital knowledge to prepare and make informed decisions during your family planning process.
“Better informed is better prepared “
The Carrier Screening provides a comprehensive picture of your risk of having a child with a genetic disorder so you can plan for your family’s future with confidence.
Benefits of Pharmacogenetic Testing
Successful pain management effectively controls patient pain without causing excess side effects from prescribed medications. Acknowledging that each patient responds differently to drugs and knowing that drugs are often the first choice of treatment for pain, pharmacogenetic testing can protect the well-being of patients, practices and medical providers. Physicians will know with certainty how patients will metabolize pharmaceuticals and the appropriate substitutions where necessary. Our partner laboratory provides an analysis of the patient’s genetic response to a specific drug for each drug tested. The goal of these results could be used to optimize drug choice and/or dose earlier for a more effective therapy.
HEREDITARY CARDIOVASCULAR DISEASES
The Cardiovascular Genetics Test panel is a comprehensive next-generation sequencing-based molecular test for inherited cardiovascular diseases. This panel includes all genes associated or potentially associated with the development of inherited cardiovascular diseases that can present sudden death as a major adverse event. The test detects genomic variations in 213 genes related to cardiovascular diseases and provides cardiologists and other physician specialists with clear genetic interpretation for risk assessment and disease diagnosis.